Tirz – 20mg
$89.00
Tirz is a ≥99% pure peptide analog supplied as a lyophilized powder for in-vitro research. Commonly studied for its interaction with GLP-1 and GIP receptor pathways in metabolic and endocrine signaling models.
For laboratory use only—no human or veterinary applications.
20 in stock
Tirz (Tirzepatide Analog) – Research Peptide
Tirz is a synthetic peptide analog studied in scientific literature for its interaction with incretin-related pathways, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor systems. These pathways have been widely explored in research models involving metabolic signaling, endocrine regulation, and peptide-receptor interactions.
In experimental settings, compounds within this class have attracted significant attention due to their dual-pathway activity, offering researchers the ability to study complex signaling mechanisms across multiple receptor systems simultaneously. This makes Tirz a compound of interest in laboratory environments focused on metabolic processes, receptor binding dynamics, and peptide-based pathway modulation.
Tirz is supplied as a lyophilized powder, allowing for controlled handling, storage, and reconstitution within research and analytical settings. Its structure and receptor activity profile make it a valuable compound for investigators studying multi-pathway peptide interactions and advanced endocrine signaling models.
At Kinesin Peptide Research, Tirz is provided strictly for research purposes only and is intended for use in controlled laboratory environments by qualified professionals. Each batch is produced with an emphasis on consistency, purity, and research-grade standards to support reliable and reproducible experimental outcomes.
Research Applications May Include:
-
GLP-1 and GIP receptor pathway studies
-
Endocrine and metabolic signaling models
-
Peptide-receptor interaction analysis
-
Multi-pathway signaling research
-
Experimental studies involving incretin-related mechanisms
